Eugia Pharma Specialties Ltd., a fully integrated subsidiary of Aurobindo Pharma, specializes in general injectables and oncology, boasting a comprehensive portfolio that spans various therapeutic areas. The company operates globally with facilities and teams in the USA, Europe, Brazil, Mexico, Canada, Colombia, ANZ, and select RoW markets, employing over 150+ scientists and 4,000+ staff worldwide. Eugia aims to build an extensive specialty portfolio. Continual investment in complex injectables and advanced R&D in Hyderabad underscores Eugia’s commitment to innovation, particularly in developing peptides, long-acting injectables, and sophisticated ophthalmic and dry powder injections.
2013